Startups

Associate Director, US Lung Analytics

Revolution Medicines · Redwood City, California, United States · On-site

← All jobs
About Revolution Medicines

Backed by GV.

About the role

Reporting to the Executive Director, Lung Analytics & Insights, the Associate Director, Lung Analytics will serve as the analytics lead for Revolution Medicines’ lung cancer portfolio. This role will partner closely with Commercial, Medical Affairs, Market Access, Clinical Development, and Business Operations to generate actionable insights that inform portfolio strategy, launch readiness, commercialization planning, and business performance. Found on 1752vc Careers, the job board for startup and VC roles.

What they're looking for

  • Bachelor’s degree required, advanced degree preferred
  • 8+ years of experience in pharmaceutical, biotechnology, healthcare analytics, or management consulting
  • Oncology analytics experience required, lung cancer experience strongly preferred
  • Demonstrated expertise working with healthcare claims, EMR, specialty pharmacy, and other patient-level datasets
  • Experience supporting oncology product launches and pre-launch planning
  • Strong analytical, problem-solving, and strategic thinking skills
More about this role

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

Reporting to the Executive Director, Lung Analytics & Insights, the Associate Director, Lung Analytics will serve as the analytics lead for Revolution Medicines’ lung cancer portfolio.

This role will partner closely with Commercial, Medical Affairs, Market Access, Clinical Development, and Business Operations to generate actionable insights that inform portfolio strategy, launch readiness,...

Read the full posting on Revolution Medicines's site ↗

US Analytics & Insights

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.